atovaquone has been researched along with Opportunistic Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asako, K; Kikuchi, H; Kitazawa, T; Kono, H; Ota, Y; Seo, K; Yoshino, Y | 1 |
| Anwer, F; Diri, R; Krishnadasan, R; McBride, A; Yeager, A | 1 |
| Borde, JP; de With, K; Offensperger, WB | 1 |
| Fishman, JA; Rodriguez, M; Sifri, CD | 1 |
| Häselbarth, K; Hunfeld, KP; Krieger, G; Kurz, M | 1 |
| Hughes, WT | 1 |
| Dickins, M; Ginger, CD; Gutteridge, WE; Holdich, T; Hudson, AT; Hutchinson, DB; Latter, VS; Pudney, M; Randall, AW | 1 |
1 review(s) available for atovaquone and Opportunistic Infections
| Article | Year |
|---|---|
[Diagnosis and treatment of pneumocystis jirovecii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Bronchoalveolar Lavage Fluid; Caspofungin; Diagnosis, Differential; Echinocandins; Humans; Lipopeptides; Lung; Opportunistic Infections; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 2011 |
6 other study(ies) available for atovaquone and Opportunistic Infections
| Article | Year |
|---|---|
Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Asthma; Atovaquone; Connective Tissue Diseases; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Opportunistic Infections; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2019 |
Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Atovaquone; Child; Child, Preschool; Dapsone; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2016 |
Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients.
Topics: Aged; Antifungal Agents; Atovaquone; Chemoprevention; Humans; Liver Transplantation; Male; Middle Aged; Naphthoquinones; Opportunistic Infections; Pneumocystis carinii; Pneumonia, Pneumocystis; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
[Babesiosis in an immunocompromised German patient].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antineoplastic Agents; Atovaquone; Azithromycin; Babesiosis; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Lymphoma, B-Cell; Male; Middle Aged; Opportunistic Infections; Rituximab; Splenectomy | 2008 |
A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia.
Topics: Antifungal Agents; Atovaquone; HIV Infections; Humans; Naphthoquinones; Opportunistic Infections; Pneumonia, Pneumocystis | 1992 |
566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients.
Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Adult; Animals; Anti-Infective Agents; Antimalarials; Aotus trivirgatus; Atovaquone; Dogs; Humans; Malaria, Falciparum; Male; Microsomes, Liver; Middle Aged; NADP; Naphthoquinones; Opportunistic Infections; Plasmodium; Rats; Toxoplasma | 1991 |